Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

12.84
Delayed Data
As of Feb 12
 +0.48 / +3.88%
Today’s Change
8.32
Today|||52-Week Range
23.30
-4.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues30.8M28.1M35.1M38.6M
 
 
 
 
 
Cost of Goods Sold2.1M1.4M1.5M2.0M
 
 
 
 
 
Depreciation And Amortization227.0K214.0K217.0K220.0K
 
 
 
 
 
 
Operating ExpensesGross Income28.5M26.5M33.3M36.3M
 
 
 
 
 
General Expenses23.8M23.1M30.2M32.0M
 
 
 
 
 
Research And Development5.8M3.7M6.9M9.1M
 
 
 
 
 
Total Operating Expenses26.1M24.7M32.0M34.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.7M3.4M3.1M4.3M
 
 
 
 
 
Extraordinary Credit694.0K0.001.0K114.0K
 
 
 
 
Extraordinary Charge0.00-2.2M-241.0K-25.0K
 
 
 
 
Interest Expense On Debt1.2M381.0K331.0K292.0K
 
 
 
 
 
Other Expenses37.0K0.0025.0K5.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.4M979.0K2.7M4.3M
 
 
 
 
 
Income Taxes0.00-62.0K-662.0K-58.0K
 
 
 
 
Net Income4.4M917.0K2.0M4.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.9M44.6M47.9M48.5M
 
 
 
 
 
Shares To Calculate EPS Diluted43.2M44.9M52.3M51.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.10$0.02$0.03$0.08
 
 
 
 
 
EPS Diluted$0.10$0.02$0.04$0.08